(MedPage Today) — CHICAGO — For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more effective and at least as safe as aspirin monotherapy in a high-risk population, a Korean randomized…
Source link : https://www.medpagetoday.com/meetingcoverage/acc/114892
Author :
Publish date : 2025-03-31 15:45:00
Copyright for syndicated content belongs to the linked Source.